Proteomics of embryonic stem cells and induced pluripotent stem cells
Researchers use inventory of embryonic stem cells and induced pluripotent stem cell proteome to do a comparison, found that the expression of two proteins have small differences, the new discovery could help to explain the two types of cells in differentiation for a particular type of ability difference, new results published online yesterday in the journal nature, methodology.
Like embryonic stem cells, ips cells can differentiate into various types of human cells. The use of ips stem cells, derived from adult tissue, avoids the ethical issues that arise when embryonic stem cells are used for research and medical treatment. The question, however, is whether ips cells are the exact biological equivalent of embryonic stem cells.
Joshua Coon and colleagues analyzed proteins from four human embryonic stem cell lines and four induced pluripotent cell lines using a proteomic analysis method based on a high-resolution mass spectrometer. Using reproducible analysis, they found reproducible differences in protein expression between the two types of stem cells. Their results showed that ips cells retained some of the characteristics of the differentiated cells from which they originated, which may have guided them to develop into specific cell types.
- October 9, 20181. SERAXIS introduced stem cell derived pancreatic cells to reverse diabetes. On September 5, SERAXIS, a regenerative medicine company, announced the successful production of stem cell-derived pancrea...view
- May 16, 2019Researchers used stem cells from human embryos to successfully treat Parkinson's disease in mice and rats. This is a key step in finding similar treatments for humans.In a study published on this sund...view
- May 16, 2019Serine threonine kinase 17A (STK17A) plays different roles in different tumors and may inhibit or promote cancer, depending on the type of cancer. But until now researchers have not understood its rol...view